Ladenburg Thalmann Financial Services’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-637
Closed -$61K 5657
2019
Q3
$61K Buy
637
+75
+13% +$7.51K ﹤0.01% 3303
2019
Q2
$57K Hold
562
﹤0.01% 3376
2019
Q1
$65K Sell
562
-770
-58% -$56.6K ﹤0.01% 3225
2018
Q4
$52K Sell
1,332
-171
-11% -$7.42K ﹤0.01% 3222
2018
Q3
$82K Buy
1,503
+969
+181% +$66.3K ﹤0.01% 2967
2018
Q2
$36K Hold
534
﹤0.01% 3492
2018
Q1
$36K Sell
534
-28
-5% -$1.62K ﹤0.01% 3492
2017
Q4
$30K Buy
562
+524
+1,379% +$37.6K ﹤0.01% 3555
2017
Q3
$3K Hold
38
﹤0.01% 4618
2017
Q2
$2K Hold
38
﹤0.01% 4657
2017
Q1
$2K Hold
38
﹤0.01% 4630
2016
Q4
$2K Hold
38
﹤0.01% 4585
2016
Q3
$2K Buy
+38
New +$2.19K ﹤0.01% 4546

Ladenburg Thalmann Financial Services's ONCE Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 637 shares — an estimated $61K sold.

Ladenburg Thalmann Financial Services first reported a position in ONCE in Q3 2016 and held it in 13 quarters. The position peaked at $82K in Q3 2018. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • Ladenburg Thalmann Financial Services reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 637 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $61K.
  • Ladenburg Thalmann Financial Services first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2016 and held it in 13 quarters.
  • Ladenburg Thalmann Financial Services's Spark Therapeutics, Inc. Common Stock position peaked at $82K in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.